We found that tumor tissues had fewer infiltrating immune cells than normal lung tissues did, and tumors from patients with early-stage SCLC presented more granzyme B+/CD8+ T cells than those from patients with late-stage SCLC did (Supplementary Fig. 3b-d). The gene discussed is CD8A; the disease is small cell lung carcinoma.